AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pournaras, S.
Right arrow Articles by Maniatis, A. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pournaras, S.
Right arrow Articles by Maniatis, A. N.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, December 2002, p. 4026-4028, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4026-4028.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Novel Variant (blaVIM-4) of the Metallo-ß-Lactamase Gene blaVIM-1 in a Clinical Strain of Pseudomonas aeruginosa

Spyros Pournaras,1* Athanassios Tsakris,2 Maria Maniati,1 Leonidas S. Tzouvelekis,3 and Antonios N. Maniatis1

Department of Medical Microbiology, University of Thessaly, Larissa,1 Department of Microbiology, Medical School, Aristotle University of Thessaloniki, Thessaloniki,2 Department of Microbiology, Medical School, University of Athens, Athens, Greece3

Received 11 April 2002/ Returned for modification 16 May 2002/ Accepted 11 September 2002

A Pseudomonas aeruginosa isolate highly resistant to carbapenems was collected from a patient with postsurgical cerebrospinal infection in Greece. The isolate carried a class 1 integron that contained as a sole cassette the gene blaVIM-4, a novel variant of blaVIM-1, with one nucleotide difference resulting in a Ser-to-Arg change at amino acid position 175 of the VIM-1 enzyme. This is the first detection of a VIM-1 variant after its appearance in Italy.


* Corresponding author. Mailing address: Department of Microbiology, Medical School, University of Thessaly, 412 22 Larissa, Greece. Phone: 30 410 682509. Fax: 30 410 682508. E-mail: spournar{at}otenet.gr.


Antimicrobial Agents and Chemotherapy, December 2002, p. 4026-4028, Vol. 46, No. 12
0066-4804/02/$04.00+0     DOI: 10.1128/AAC.46.12.4026-4028.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.